Hutton DW, Prosser LA, Rose AM, Mercon K, et al. Cost-Effectiveness of Nirsevimab for Respiratory Syncytial Virus in Infants and Young Children. Pediatrics 2024 Nov 25:e2024066461. doi: 10.1542/peds.2024-066461.
PMID: 39582316